Replimune (REPL) Payables (2018 - 2025)

Replimune has disclosed Payables across 8 years of filings, most recently posting $5.6 million for Q4 2025.

• Payables for Q4 2025 came in at $5.6 million, down 21.44% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.6 million (down 21.44% YoY), and the FY2025 annual result was $12.5 million, up 383.44% from the prior year.
• Payables came in at $5.6 million for Q4 2025 at Replimune, down from $6.4 million in the prior quarter.
• In the past five years, Payables ranged from a high of $15.5 million in Q2 2025 to a low of $864000.0 in Q2 2024.
• The 5-year median for Payables is $4.2 million (2022), against an average of $5.3 million.
• Across the five-year window, Payables sank 82.31% in 2024 and jumped 1692.01% in 2025, its largest moves.
• Replimune's Payables stood at $3.9 million in 2021, then slipped by 6.99% to $3.6 million in 2022, then rose by 6.99% to $3.9 million in 2023, then surged by 84.17% to $7.2 million in 2024, then declined by 21.44% to $5.6 million in 2025.
• The last three Payables figures came in at $5.6 million (Q4 2025), $6.4 million (Q3 2025), and $15.5 million (Q2 2025), per Business Quant data.